Terms: = Thyroid cancer AND CEACAM5, CEA AND Treatment
142 results:
1. Prognostic value of pretreatment FDG PET-CT for short-term efficacy of radioactive iodine-125 seed implantation in patients with NSCLC.
Hu T; Shen J; Shao M; Feng X; Lu D; Ding E
Brachytherapy; 2023; 22(6):882-888. PubMed ID: 37758577
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the application value of pro-gastrin-releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma.
Miao Q; Lv X; Luo L; Zhang J; Cai B
Cancer Med; 2023 Oct; 12(19):19576-19582. PubMed ID: 37754747
[TBL] [Abstract] [Full Text] [Related]
3. Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer.
Su Q; Wang X; Zhu R; Liu C; Sun S
Sci Rep; 2023 Sep; 13(1):14791. PubMed ID: 37684327
[TBL] [Abstract] [Full Text] [Related]
4. Other markers of medullary thyroid cancer, not only calcitonin.
Censi S; Manso J; Mian C
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167
[TBL] [Abstract] [Full Text] [Related]
5. Lobectomy may be more appropriate for patients with early-stage medullary thyroid cancer older than 60 years old.
Yang B; Niu G; Li X; Ma F; Ma Y; Hu S
Front Endocrinol (Lausanne); 2022; 13():1015319. PubMed ID: 36339396
[TBL] [Abstract] [Full Text] [Related]
6. A Rare Case of Negative Serum Calcitonin in Metastatic Medullary thyroid Carcinoma: Diagnosis, treatment, and Follow-Up Strategy.
Licata L; Di Fidio CA; Vacante M; Basile F; Biondi A; Richiusa P; Gurrera A; Ciuni R
Am J Case Rep; 2022 Sep; 23():e935207. PubMed ID: 36088532
[TBL] [Abstract] [Full Text] [Related]
7. Advantages and clinical significance of enhanced CT combined with BRAF V600E gene detection in the diagnosis of papillary thyroid carcinoma.
Zhang J; Zhang J; Han J
Med Eng Phys; 2022 Dec; 110():103862. PubMed ID: 35933302
[TBL] [Abstract] [Full Text] [Related]
8. Vascular Endothelial Growth Factor Receptor Inhibitors in Chinese Patients With Advanced Radioactive Iodine-Refractory Differentiated thyroid cancer: A Network Meta-Analysis and Cost-Effectiveness Analysis.
Zhu Y; Liu K; Wang K; Peng L
Front Endocrinol (Lausanne); 2022; 13():909333. PubMed ID: 35909569
[TBL] [Abstract] [Full Text] [Related]
9. Brain metastasis from calcitonin-negative medullary thyroid carcinoma.
Baptista PF; Fonseca LCM; Carvalho AFC; Silva SNVD; Freitas CRO
Ann Endocrinol (Paris); 2022 Aug; 83(4):258-260. PubMed ID: 35537523
[TBL] [Abstract] [Full Text] [Related]
10. Prospective study on the clinical relevance of
Califano I; Pitoia F; Chirico R; De Salazar A; Bastianello MJ
Endocrine; 2022 Jun; 77(1):143-150. PubMed ID: 35489000
[TBL] [Abstract] [Full Text] [Related]
11. Continued Discontinuation of TKI treatment in Medullary thyroid Carcinoma - Lessons From Individual Cases With Long-Term Follow-Up.
Brandenburg T; Tiedje V; Muchalla P; Theurer S; Weber F; Schmid KW; Dralle H; Führer D
Front Endocrinol (Lausanne); 2021; 12():718418. PubMed ID: 34659114
[TBL] [Abstract] [Full Text] [Related]
12. The Concept of Economic Evaluation and Its Application in thyroid cancer Research.
Kim K; Kim M; Lim W; Kim BH; Park SK
Endocrinol Metab (Seoul); 2021 Aug; 36(4):725-736. PubMed ID: 34474512
[TBL] [Abstract] [Full Text] [Related]
13. Parotid saliva
Rovera A; Hector M; Anderson P
Spec Care Dentist; 2022 Jan; 42(1):80-85. PubMed ID: 34293207
[TBL] [Abstract] [Full Text] [Related]
14. A Review of the Significance in Measuring Preoperative and Postoperative Carcinoembryonic Antigen (cea) Values in Patients with Medullary thyroid Carcinoma (MTC).
Passos I; Stefanidou E; Meditskou-Eythymiadou S; Mironidou-Tzouveleki M; Manaki V; Magra V; Laskou S; Mantalovas S; Pantea S; Kesisoglou I; Sapalidis K
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34208296
[No Abstract] [Full Text] [Related]
15. Joint Detection of Tap and cea Based on Deep Learning Medical Image Segmentation: Risk Prediction of thyroid cancer.
Lang S; Xu Y; Li L; Wang B; Yang Y; Xue Y; Shi K
J Healthc Eng; 2021; 2021():5920035. PubMed ID: 34158913
[TBL] [Abstract] [Full Text] [Related]
16. Elevated basal serum levels of calcitonin and simultaneous surgery of MEN2A-specific tumors.
Tang HX; Yang H; Li F; Cao ZL; Huang YT; Qi XP
Neoplasma; 2021 Sep; 68(5):1098-1106. PubMed ID: 34156257
[TBL] [Abstract] [Full Text] [Related]
17. TAP Test Image Dynamic Tracking Study after thyroid cancer Surgery and after Radiotherapy and Chemotherapy.
Wang C; Gu Y; Men X; Sun P; Chen M
Comput Math Methods Med; 2021; 2021():8072126. PubMed ID: 33953794
[TBL] [Abstract] [Full Text] [Related]
18. Circulating pro-gastrin releasing peptide (ProGRP) in patients with medullary thyroid carcinoma.
Giovanella L; Fontana M; Keller F; Campenni' A; Ceriani L; Paone G
Clin Chem Lab Med; 2021 Aug; 59(9):1569-1573. PubMed ID: 33860650
[TBL] [Abstract] [Full Text] [Related]
19. Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer.
Matrone A; Prete A; Nervo A; Ragni A; Agate L; Molinaro E; Giani C; Valerio L; Minaldi E; Piovesan A; Elisei R
J Endocrinol Invest; 2021 Oct; 44(10):2139-2151. PubMed ID: 33594641
[TBL] [Abstract] [Full Text] [Related]
20. An Overview of Medullary thyroid cancer Cases Treated at Kuwait cancer Control Center.
Shete J; AlSaleh K; Safwat R; Bedair A; ElSherify M; Hussein A; Nazeeh M; Mohanty A
Gulf J Oncolog; 2020 Sep; 1(34):39-47. PubMed ID: 33431361
[TBL] [Abstract] [Full Text] [Related]
[Next]
